Orthostatic responses in adolescent CFS
A persistent challenge in ME/CFS research and clinical care has been making the invisible measurable. Symptoms like fatigue, cognitive impairment, and post-exertional malaise are real, they are disabling, and they resist simple quantification — which has enabled decades of dismissal by clinicians who conflate "not easily measured" with "not real." A 2014 study by Wyller and colleagues in BioPsychoSocial Medicine provides the kind of objective cardiovascular evidence that closes one important part of that gap: autonomic dysregulation in adolescent ME/CFS is measurable, reproducible, and present not only during orthostatic challenge but at rest and in anticipation of activity.
Study Design: Two Orthostatic Protocols and a Resting Baseline
Wyller and colleagues recruited 30 adolescent patients with CFS aged 12 to 18 and 39 healthy controls matched for age and sex. They applied two protocols: a 20-degree head-up tilt — a moderate orthostatic challenge — and a motor imagery protocol in which participants were asked to vividly imagine standing upright without actually doing so. Both protocols were preceded by supine baseline measurements. Heart rate, blood pressure, heart rate variability, and multiple spectral indices of sympathovagal balance were recorded throughout.
The design allowed the researchers to distinguish three distinct states: supine rest, actual orthostatic challenge, and imagined orthostatic challenge. This was methodologically important because it separated the direct physiological effects of posture from the anticipatory central nervous system response to the expectation of postural stress.
The Resting Baseline: Dysregulation Before the Challenge Begins
The supine baseline data were the first significant finding. At rest — before any orthostatic challenge — ME/CFS patients already showed significantly higher heart rate, higher blood pressure, and lower heart rate variability indices compared to healthy controls. Lower HRV in this context indicates sympathetic predominance: the autonomic balance is shifted away from parasympathetic (rest-and-digest) tone toward sympathetic (fight-or-flight) tone, even when lying flat and at rest.
This is not an orthostatic response. It is a resting dysregulation. The autonomic system in these adolescent ME/CFS patients is operating with elevated sympathetic tone as its baseline operating state — before any gravitational challenge has been applied. The tachycardia and cardiovascular dysregulation these patients experience when upright is not starting from the same place as healthy controls. It is starting from an already-dysregulated resting state and escalating from there.
This finding directly undermines the clinical assumption that ME/CFS patients who look normal lying down are physiologically unremarkable. The quantitative autonomic data says otherwise: the dysregulation is present in the supine state, measurable with standard cardiovascular instrumentation.
Anticipatory Activation: The Body Responds to the Expectation of Upright
The motor imagery protocol produced the study's most clinically novel finding. When ME/CFS patients were asked to imagine standing upright — without physically changing position — they showed a significantly stronger increase in sympathetic-predominance indices compared to healthy controls who performed the same imagery task.
Healthy controls showed modest cardiovascular responses to imagined upright posture — a normal motor imagery effect consistent with the known tendency for motor imagery to activate some of the same neural circuits as actual movement. ME/CFS patients showed substantially amplified versions of this effect. The autonomic nervous system was responding to the anticipated orthostatic stress before that stress was physically applied.
This has a name in the predictive processing literature: anticipatory autonomic activation. The central nervous system is generating a threat prediction — upright posture will be physiologically demanding — and the autonomic system is beginning to mobilize its compensatory responses before the threat arrives. For ME/CFS patients, this means the physiological cost of anticipating activity begins well before the activity starts. It also means that the apparent relationship between activity and post-exertional malaise is not simply linear — anticipation of demanding activities may itself produce measurable autonomic activation that contributes to the symptom burden.
Reproducibility: This Is Not Noise, It Is Signal
The study design included repeat measurements, allowing the researchers to assess whether the autonomic dysregulation findings were reproducible. They were. The elevated resting sympathetic tone, the amplified orthostatic tilt responses, and the exaggerated anticipatory motor imagery responses were consistent across repeated measurements in the same patients. This reproducibility matters for several reasons.
First, it establishes that the dysregulation is a stable feature of the condition rather than an artifact of a single bad day or measurement noise. Second, it provides the methodological groundwork for using these measures as outcomes in treatment research — if they are reproducible, they can be used to measure whether interventions change the autonomic profile. Third, it reinforces the case that ME/CFS involves a measurable, objective physiological state that can be characterized with standard cardiovascular equipment, not just inferred from symptom reports.
The Diagnostic Gap This Research Exposes
Standard evaluation of ME/CFS patients in most clinical settings involves symptom assessment, basic blood work, and sometimes a 10-minute standing test with heart rate and blood pressure monitoring. The Wyller data establish that this protocol misses two of the three significant findings: resting autonomic dysregulation (visible with HRV analysis, not standard vital signs) and anticipatory autonomic activation (visible only if you assess responses to imagery or expectation, not just to physical challenge).
An adolescent patient with ME/CFS who undergoes a standard evaluation will show unremarkable vital signs while lying flat, show modest or absent blood pressure changes during a brief stand test, and receive a report indicating no significant objective findings. The Wyller data say that the objective findings were not absent. They were not measured with the tools that were used.
What the reader now has: evidence that the autonomic dysregulation in adolescent ME/CFS is measurable before, during, and in anticipation of orthostatic challenge. The invisibility of this condition in standard evaluations is not evidence that the physiology is absent. It is evidence that the evaluations are using the wrong instruments.